On October 26, 2020, the Food and Drug Administration (FDA) issued its long awaited final MOU which describes the conditions under which certain compounded drugs by a pharmacist in a state-licensed pharmacy, or by a licensed physician, are exempt... Read More
Frier Levitt Partner, Todd Mizeski, Esq. has an article featured in the current issue of Drug Topics discussing the Rutledge v. Pharmaceutical Care Management Association case that recently went before the Supreme Court (SCOTUS). The SCOTUS’s... Read More
With the November elections looming, the policy environment for pharmacy issues hangs in the balance. Who will control the halls of Congress as well as the state legislature will be key in determining the pace of pharmacy legislation. Over... Read More
